Medical Testing

Paxlovid Misses in Standard-Risk COVID-19 Trend toward advantage in secondary endpoint of hospitalization or death, but not significant Kristina Fiore medpagetoday

Updated findings from a nirmatrelvir/ritonavir (Paxlovid) trial in standard-risk COVID-19 suggest the antiviral's benefits are less clear for those not at high risk of severe outcomes.

Florida is the only state to skip pre-ordering Covid-19 vaccines for kids Florida’s Department of Health is led by state Surgeon General Joe Ladapo, an outspoken skeptic of the Covid-19 vaccine. POLITICO

...

The Florida Department of Health, through a statement, said Wednesday that it did not place an order with the federal government for vaccine doses for kids five and under in part because it doesn’t advise all children get vaccinated. The deadline for placing a pre-order was Tuesday and 49 other states met the cutoff date...

FDA advisers vote in favor of authorizing Moderna Covid-19 vaccine for ages 6-17 Vaccine advisers to the US Food and Drug Administration decided unanimously Tuesday in favor of expanding the emergency use authorization of Moderna's Covid-19 vaccine to include older children and teens, ages 6 to 17, saying it would offer more benefits than risks. Jacqueline Howard, CNN CNN

...

COVID Vax a Must at the Border; WHO to Rename Monkeypox; Abortions Rose in 2020 A daily roundup of news on COVID-19 and the rest of medicine Joyce Frieden medpagetoday

...